In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Avalo Therapeutics Inc’s stock clocked out at $4.94, up 2.07% from its previous closing price of $4.84. In other words, the price has increased by $2.07 from its previous closing price. On the day, 0.55 million shares were traded. AVTX stock price reached its highest trading level at $5.0 during the session, while it also had its lowest trading level at $4.76.
Ratios:
To gain a deeper understanding of AVTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.61 and its Current Ratio is at 22.61. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On March 25, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $36.
On March 25, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $23.Jefferies initiated its Buy rating on March 25, 2025, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 13 ’24 when Almenoff June Sherie bought 500 shares for $13.00 per share. The transaction valued at 6,500 led to the insider holds 1,000 shares of the business.
Almenoff June Sherie bought 500 shares of AVTX for $6,250 on Nov 12 ’24. The Director now owns 500 shares after completing the transaction at $12.50 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVTX now has a Market Capitalization of 53488344 and an Enterprise Value of -70215176. For the stock, the TTM Price-to-Sale (P/S) ratio is 121.57 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at -159.218 whereas that against EBITDA is 1.403.
Stock Price History:
The Beta on a monthly basis for AVTX is 0.77, which has changed by -0.6076251 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, AVTX has reached a high of $16.00, while it has fallen to a 52-week low of $3.39. The 50-Day Moving Average of the stock is 10.70%, while the 200-Day Moving Average is calculated to be -36.28%.
Shares Statistics:
It appears that AVTX traded 74.93K shares on average per day over the past three months and 128510 shares per day over the past ten days. A total of 10.83M shares are outstanding, with a floating share count of 8.61M. Insiders hold about 20.47% of the company’s shares, while institutions hold 62.85% stake in the company. Shares short for AVTX as of 1749772800 were 83831 with a Short Ratio of 1.12, compared to 1747267200 on 86488. Therefore, it implies a Short% of Shares Outstanding of 83831 and a Short% of Float of 0.7799999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
